An Interactive Web Platform to Teach Children Hunting, Shooting & Firearms

Status Completed

Clinical Trial Summary

Firearms injuries present a major pediatric public health challenge, killing >800 children ages 0-15 annually and leading to lifelong disability among >1000 survivors. About ⅓ of firearms injuries to children under age 15 are due to unintentional causes rather than suicide or homicide. The investigators propose development and evaluation of ShootSafe, an innovative, engaging, and educational website accessible by smartphone, tablet or computer that engages children to learn firearms safety. ShootSafe extends existing programs to achieve 3 primary goals: a) teach children knowledge and skills they need to hunt, shoot, and use firearms safely; b) help children learn and hone critical cognitive skills of impulse control and hypothetical thinking needed to use firearms safely; and c) alter children's perceptions about their own vulnerability and susceptibility to firearms-related injuries, the severity of those injuries, and their perceived norms about peer behavior surrounding firearms use. ShootSafe will accomplish these goals through a combination of interactive games plus podcast videos delivered by peer actors (impactful testimonials about firearms injuries/deaths they experienced) and experts (wisdom & experience from trusted role models). The website will also incorporate brief messaging to parents, who will absorb key lessons and reinforce them with their children. The website will be evaluated through a randomized controlled trial with 162 children ages 10-12, randomly assigning children to engage in the ShootSafe website or an active control website on child nutrition. The investigators will incorporate sub-aims to evaluate changes in children's (a) knowledge, (b) cognitive skills in impulse control and hypothetical thinking, (c) perceptions about firearms safety, and (d) simulated behavior when handling, storing and transporting firearms. All outcome measures will be assessed at baseline, immediately post-intervention, and at a 4-month follow-up assessment to evaluate retention. Training will comprise two 30-minute sessions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04622943
Study type	Interventional
Source	University of Alabama at Birmingham
Contact
Status	Completed
Phase	N/A
Start date	December 14, 2021
Completion date	May 10, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04485481` - Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers	Phase 1
Completed	`NCT03473236` - Phase 1A Safety Trial of Inhaled PK10571 (GB002)	Phase 1
Not yet recruiting	`NCT03683953` - The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells	Phase 1
Recruiting	`NCT05546567` - NOPARK Open Label Extension Study	N/A
Recruiting	`NCT05413226` - Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility	N/A
Recruiting	`NCT05112159` - Study of IPG1094 in Healthy Participants	Phase 1
Completed	`NCT04689035` - A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144	Phase 1
Completed	`NCT04335045` - Phase I Study of PH100 (Ecklonia Cava Phlorotannins)	Phase 1
Completed	`NCT05037227` - Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia
Recruiting	`NCT05517291` - DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease	N/A
Enrolling by invitation	`NCT06446778` - Haemodynamic Mechanisms and Multicentre Prospective Cohort Study of the Pipeline Flow-diverting Device for the Treatment of Intracranial Aneurysms. Evaluation of the Safety and Efficacy of the Pipeline Flow-diverting Device for the Treatment of Intracranial Aneurysms
Recruiting	`NCT04573049` - The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement	Phase 4
Completed	`NCT05585463` - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Completed	`NCT04188821` - Reduction of Seroma and Improvement of QoL in Breast Reconstruction With Tissue Expander	N/A
Completed	`NCT03667430` - Safety Evaluation of Porous Silica in Men	N/A
Completed	`NCT04499482` - Safety and Tolerability of Soy Fiber	N/A
Completed	`NCT03141905` - Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease	N/A
Completed	`NCT05244161` - A Quasi-experimental Evaluation of the Malezi Program in Tanzania	N/A
Recruiting	`NCT03791372` - Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy	Phase 1
Withdrawn	`NCT04759066` - The HEALiX™ Intubated Patient (IP) Pilot Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

An Interactive Web Platform to Teach Children Hunting, Shooting and Firearms Safety

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms